SMOKING CESSATION
One of the most important factors in the management of patients with COPD is the cessation of cigarette smoking. Susceptible smokers who develop COPD have an increased rate of decline in lung function measured as FEVa (80 ml/yr) compared to nonsusceptible smokers and nonsmokers (30 ml/yr) (Fig. 19-2]. Following cessation of smoking, the rate of decline in the susceptible smoker is reduced to that in the nonsmoker (30 ml/yr).
- NORMAL INTESTINAL PHYSIOLOGY
- Renal Tumors
- PATHOLOGY
- V-GASTROINTESTINAL DISEASE
- Neurologic Manifestations
- PULMONARY GAS EXCHANGE
- Studies of Pancreatic Structure and Function
- Hepatic Diseases
- PHYSIOLOGY OF THE CORONARY CIRCULATION
- Sarcoidosis
- Systemic Vasculitides
- ACUTE RENAL INSUFFICIENCY
- Pulmonary Vasculitis
- VENTILATION
- CONSTRICTIVE PERICARDITIS
- Proliferative Glomerulonephritis
- Renal Biopsy and Other Diagnostic Tests
- Blood Chemistries
- Urolithiasis
- Focal Glomerular Sclerosis (FQS)
- LABORATORY TESTS TOR BILIRUBIN
- HYPERKINETIC PULMONARY HYPERTENSION
- Mesangioproliferative Glomerulonephritis
- THE FAMILIAL POLYPOSIS SYNDROMES
- Etiology and Pathogenesis
- DIAGNOSTIC TECHNIQUES AND THEIR INDICATIONS - IMAGING PROCEDURES
- CIRCULATORY PHYSIOLOGY
- Diagnosis
- OTHER ESOPHAGEAL DISORDERS
- AV JUNCTIONAL RHYTHM DISTURBANCES
- ATRIAL RHYTHM DISTURBANCES
- RADIOGRAPHIC AND ENDOSCOPIC PROCEDURES IN GASTROENTEROLOGY
- Beta Blockers
- CARCINOMA OF THE PANCREAS - Diagnosis
- Amiodarone